88 related articles for article (PubMed ID: 26728674)
1. Transcatheter arterial infusion chemotherapy increases expression level of miR-142-5p in stage III colorectal cancer.
Shi D; Zhai B; Zheng Y; Ren R; Han M; Wang X
Indian J Cancer; 2015 Dec; 52 Suppl 2():e47-55. PubMed ID: 26728674
[TBL] [Abstract][Full Text] [Related]
2. High microRNA-28-5p expression in colorectal adenocarcinoma predicts short-term relapse of node-negative patients and poor overall survival of patients with non-metastatic disease.
Tsiakanikas P; Kontos CK; Kerimis D; Papadopoulos IN; Scorilas A
Clin Chem Lab Med; 2018 May; 56(6):990-1000. PubMed ID: 29688883
[TBL] [Abstract][Full Text] [Related]
3. Up-regulated miR-155-5p promotes cell proliferation, invasion and metastasis in colorectal carcinoma.
Qu YL; Wang HF; Sun ZQ; Tang Y; Han XN; Yu XB; Liu K
Int J Clin Exp Pathol; 2015; 8(6):6988-94. PubMed ID: 26261588
[TBL] [Abstract][Full Text] [Related]
4. miR-150 as a potential biomarker associated with prognosis and therapeutic outcome in colorectal cancer.
Ma Y; Zhang P; Wang F; Zhang H; Yang J; Peng J; Liu W; Qin H
Gut; 2012 Oct; 61(10):1447-53. PubMed ID: 22052060
[TBL] [Abstract][Full Text] [Related]
5. Clinical and biological significance of miR-378a-3p and miR-378a-5p in colorectal cancer.
Li H; Dai S; Zhen T; Shi H; Zhang F; Yang Y; Kang L; Liang Y; Han A
Eur J Cancer; 2014 Apr; 50(6):1207-21. PubMed ID: 24412052
[TBL] [Abstract][Full Text] [Related]
6. Overexpression of miR-21-5p as a predictive marker for complete tumor regression to neoadjuvant chemoradiotherapy in rectal cancer patients.
Lopes-Ramos CM; Habr-Gama A; Quevedo Bde S; Felício NM; Bettoni F; Koyama FC; Asprino PF; Galante PA; Gama-Rodrigues J; Camargo AA; Perez RO; Parmigiani RB
BMC Med Genomics; 2014 Dec; 7():68. PubMed ID: 25496125
[TBL] [Abstract][Full Text] [Related]
7. Overexpression of microRNA-183 in human colorectal cancer and its clinical significance.
Zhou T; Zhang GJ; Zhou H; Xiao HX; Li Y
Eur J Gastroenterol Hepatol; 2014 Feb; 26(2):229-33. PubMed ID: 24150523
[TBL] [Abstract][Full Text] [Related]
8. The potential value of miR-1 and miR-374b as biomarkers for colorectal cancer.
Wu X; Li S; Xu X; Wu S; Chen R; Jiang Q; Li Y; Xu Y
Int J Clin Exp Pathol; 2015; 8(3):2840-51. PubMed ID: 26045793
[TBL] [Abstract][Full Text] [Related]
9. Down-regulation of let-7a-5p predicts lymph node metastasis and prognosis in colorectal cancer: Implications for chemotherapy.
Liu TP; Huang CC; Yeh KT; Ke TW; Wei PL; Yang JR; Cheng YW
Surg Oncol; 2016 Dec; 25(4):429-434. PubMed ID: 27262492
[TBL] [Abstract][Full Text] [Related]
10. The deoxycholic acid targets miRNA-dependent CAC1 gene expression in multidrug resistance of human colorectal cancer.
Kong Y; Bai PS; Sun H; Nan KJ; Chen NZ; Qi XG
Int J Biochem Cell Biol; 2012 Dec; 44(12):2321-32. PubMed ID: 22903020
[TBL] [Abstract][Full Text] [Related]
11. miR-15a-5p, A Novel Prognostic Biomarker, Predicting Recurrent Colorectal Adenocarcinoma.
Kontos CK; Tsiakanikas P; Avgeris M; Papadopoulos IN; Scorilas A
Mol Diagn Ther; 2017 Aug; 21(4):453-464. PubMed ID: 28405803
[TBL] [Abstract][Full Text] [Related]
12. Upregulation of miR-101 enhances the cytotoxic effect of anticancer drugs through inhibition of colon cancer cell proliferation.
Chen LG; Xia YJ; Cui Y
Oncol Rep; 2017 Jul; 38(1):100-108. PubMed ID: 28560419
[TBL] [Abstract][Full Text] [Related]
13. Downregulation of miR-195 correlates with lymph node metastasis and poor prognosis in colorectal cancer.
Wang X; Wang J; Ma H; Zhang J; Zhou X
Med Oncol; 2012 Jun; 29(2):919-27. PubMed ID: 21390519
[TBL] [Abstract][Full Text] [Related]
14. Plasma levels of microRNA-24, microRNA-320a, and microRNA-423-5p are potential biomarkers for colorectal carcinoma.
Fang Z; Tang J; Bai Y; Lin H; You H; Jin H; Lin L; You P; Li J; Dai Z; Liang X; Su Y; Hu Q; Wang F; Zhang ZY
J Exp Clin Cancer Res; 2015 Aug; 34(1):86. PubMed ID: 26297223
[TBL] [Abstract][Full Text] [Related]
15. MicroRNA-17-5p promotes chemotherapeutic drug resistance and tumour metastasis of colorectal cancer by repressing PTEN expression.
Fang L; Li H; Wang L; Hu J; Jin T; Wang J; Yang BB
Oncotarget; 2014 May; 5(10):2974-87. PubMed ID: 24912422
[TBL] [Abstract][Full Text] [Related]
16. Decreased Expression of MIR-134 and its Clinical Significance in Human Colorectal Cancer.
Xie Y; Song J; Zong Q; Wang A; Yang Y; Liu F; Meng X
Hepatogastroenterology; 2015 May; 62(139):615-9. PubMed ID: 26897940
[TBL] [Abstract][Full Text] [Related]
17. Serum microRNA-135a-5p as an auxiliary diagnostic biomarker for colorectal cancer.
Wang Q; Zhang H; Shen X; Ju S
Ann Clin Biochem; 2017 Jan; 54(1):76-85. PubMed ID: 27126269
[TBL] [Abstract][Full Text] [Related]
18. Regulation of microRNA-1288 in colorectal cancer: altered expression and its clinicopathological significance.
Gopalan V; Pillai S; Ebrahimi F; Salajegheh A; Lam TC; Le TK; Langsford N; Ho YH; Smith RA; Lam AK
Mol Carcinog; 2014 Feb; 53 Suppl 1():E36-44. PubMed ID: 24009195
[TBL] [Abstract][Full Text] [Related]
19. MicroRNA expression profiling and Notch1 and Notch2 expression in minimal deviation adenocarcinoma of uterine cervix.
Lee H; Kim KR; Cho NH; Hong SR; Jeong H; Kwon SY; Park KH; An HJ; Kim TH; Kim I; Yoon HK; Suh KS; Min KO; Choi HJ; Park JY; Yoo CW; Lee YS; Lee HJ; Lee WS; Park CS; Lee Y;
World J Surg Oncol; 2014 Nov; 12():334. PubMed ID: 25381598
[TBL] [Abstract][Full Text] [Related]
20. Enhanced miR-182 transcription is a predictor of poor overall survival in colorectal adenocarcinoma patients.
Rapti SM; Kontos CK; Papadopoulos IN; Scorilas A
Clin Chem Lab Med; 2014 Aug; 52(8):1217-27. PubMed ID: 24615484
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
